Author details

Full Name

Lori A Ramkissoon

Affiliation

ORCID

Career Start Year

2013

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37619245	A Retrospective Genomic Landscape of 661 Young Adult Glioblastomas Diagnosed Using 2016 WHO Guidelines for Central Nervous System Tumors.	Oncologist	2024
37365170	A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease.		2023
36780194	ALK Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma.	Clin Cancer Res	2023
33648805	Applications of next-generation sequencing in hematologic malignancies.	Human Immunology	2021
34151687	Clonal evolution of Philadelphia chromosome in acute myeloid leukemia after enasidenib treatment.	Leukemia and Lymphoma	2021
32555414	Correction: An approach to integrating exome sequencing for fetal structural anomalies into clinical practice.	Genet Med	2020
31747025	PIK3CA Mutation in HPV-Associated OPSCC Patients Receiving Deintensified Chemoradiation.	J Natl Cancer Inst	2020
31995621	Clinical management and genomic profiling of pediatric low-grade gliomas in Saudi Arabia.	PLoS One	2020
31974414	An approach to integrating exome sequencing for fetal structural anomalies into clinical practice.	Genet Med	2020
33192972	Genomic Profiling of Circulating Tumor DNA From Cerebrospinal Fluid to Guide Clinical Decision Making for Patients With Primary and Metastatic Brain Tumors.	Front Neurol	2020
32853555	Genomic Sequencing for Newborn Screening: Results of the NC NEXUS Project.	Am J Hum Genet	2020
29167275	Residual Convolutional Neural Network for the Determination of <i>IDH</i> Status in Low- and High-Grade Gliomas from MR Imaging.	Clin Cancer Res	2018
29931654	Precision Neuro-oncology: the Role of Genomic Testing in the Management of Adult and Pediatric Gliomas.	Curr Treat Options Oncol	2018
28104717	Clinical targeted exome-based sequencing in combination with genome-wide copy number profiling: precision medicine analysis of 203 pediatric brain tumors.	Neuro Oncol	2017
28035683	Nuclear inclusion bodies of mutant and wild-type p53 in cancer: a hallmark of p53 inactivation and proteostasis remodelling by p53 aggregation.	J Pathol	2017
28082416	A brain-penetrant RAF dimer antagonist for the noncanonical BRAF oncoprotein of pediatric low-grade astrocytomas.	Neuro Oncol	2017
27270588	Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases.	Nat Med	2016
27175596	MAPK activation and HRAS mutation identified in pituitary spindle cell oncocytoma.	Oncotarget	2016
26829751	MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism.	Nat Genet	2016
25825052	Expression profiles of 151 pediatric low-grade gliomas reveal molecular differences associated with location and histological subtype.	Neuro Oncol	2015
25754088	Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma.	Neuro Oncol	2015
25366336	Preclinical antitumor efficacy of selective exportin 1 inhibitors in glioblastoma.	Neuro-Oncology	2015
24705250	Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma.	Nat Genet	2014
25257301	Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomas.	Oncotarget	2014
24395742	Pten loss in Olig2 expressing neural progenitor cells and oligodendrocytes leads to interneuron dysplasia and leukodystrophy.	Stem Cells	2014
24589977	Pediatric low-grade gliomas: how modern biology reshapes the clinical field.	Biochim Biophys Acta	2014
23633565	Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1.	Proc Natl Acad Sci U S A	2013